Lee Pharmaceuticals Inc


Prices are adjusted according to historical splits.

Lee Pharmaceuticals Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
Book Value:
Revenue TTM:
$8.92 million
Operating Margin TTM:
Gross Profit TTM:
$3.03 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Lee Pharmaceuticals Inc had its IPO on under the ticker symbol LPHM.

The company operates in the Technology sector and Software-Application industry. Lee Pharmaceuticals Inc has a staff strength of 1 employees.

Stock update

Shares of Lee Pharmaceuticals Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.05, and closed at $0.05.

This is a -5.85% slip from the previous day's closing price.

A total volume of 700 shares were traded at the close of the day’s session.

In the last one week, shares of Lee Pharmaceuticals Inc have slipped by -16.69%.

Lee Pharmaceuticals Inc's Key Ratios

Lee Pharmaceuticals Inc has a market cap of $273201, indicating a price to book ratio of 0 and a price to sales ratio of 0.0311.

In the last 12-months Lee Pharmaceuticals Inc’s revenue was $8.92 million with a gross profit of $3.03 million and an EBITDA of $-194000. The EBITDA ratio measures Lee Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Lee Pharmaceuticals Inc’s operating margin was 0% while its return on assets stood at -1670.94% with a return of equity of 0%.

In Q2, Lee Pharmaceuticals Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 30%.

Lee Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.12 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lee Pharmaceuticals Inc’s profitability.

Lee Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0.8202 and a EV to EBITDA ratio of -22.2334. Its price to sales ratio in the trailing 12-months stood at 0.0311.

Lee Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
Total Liabilities
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Lee Pharmaceuticals Inc ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Lee Pharmaceuticals Inc ended 2024 with $0 in deferred long-term liabilities, $555295.00 in other current liabilities, 5162.00 in common stock, $-5317095.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Lee Pharmaceuticals Inc’s total current assets stands at $13168.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Lee Pharmaceuticals Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Lee Pharmaceuticals Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Lee Pharmaceuticals Inc stock is currently trading at $0.05 per share. It touched a 52-week high of $0.4 and a 52-week low of $0.4. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.08 and 200-day moving average was $0.14 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Lee Pharmaceuticals Inc

The stock symbol (also called stock or share ticker) of Lee Pharmaceuticals Inc is LPHM

The IPO of Lee Pharmaceuticals Inc took place on

Similar Industry Stocks (Software-Application)

Last Price
Xometry Inc (XMTR)
CorVel Corp (CRVL)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Lee Pharmaceuticals, Inc., through its subsidiary, RONN Motor Group, Inc., focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was founded in 2013 and is based in Scottsdale, Arizona.


1434 Santa Anita Avenue, South El Monte, CA, United States, 91733